Purpose

This paper aims to understand how the global supply chain in the medical device industry embraces resilience by adopting agility approach following COVID-19.

Design/methodology/approach

This study adopts an interpretative approach to examine the qualitative data drawn from interviews and observation under dynamic capability theory. The data collection concerned multiple stakeholders involved in purchasing and supply management in the medical device market: manufacturing suppliers, channel partners, hospital management and end-users. The coding analysis uses an application that helps the researchers categorise the nodes and extend the existing literature.

Findings

The findings show that global supply chain leaders leverage the dynamic capability by centralising the business process decision to respond to the shifting demand from the local governments to the national health ministry, shaping the partnership style from the area- to the funnel-based agreement, even though it exposes a risk of product acceptability from the end-users, encouraging the distributor to convert just-in-time approach into holding safety stock to avoid penalty from missing the procurement target even and restructuring the local partners’ debts to manage long-term performance.

Originality/value

This study extends the emerging literature in international business by underpinning dynamic capability theory.

中文翻译：

---

增强印尼医疗器械行业的全球供应链弹性：动态能力视角

目的

本文旨在了解医疗器械行业的全球供应链如何在 COVID-19 之后通过采用敏捷方法来拥抱弹性。

设计/方法/途径

本研究采用解释性方法来检验根据动态能力理论从访谈和观察中提取的定性数据。数据收集涉及参与医疗器械市场采购和供应管理的多个利益相关者：制造供应商、渠道合作伙伴、医院管理层和最终用户。编码分析使用一个应用程序帮助研究人员对节点进行分类并扩展现有文献。

发现

调查结果表明，全球供应链领导者通过集中业务流程决策来响应从地方政府到国家卫生部的不断变化的需求，从而利用动态能力，塑造从区域协议到漏斗协议的合作方式，甚至尽管它暴露了最终用户接受产品的风险，但鼓励分销商将准时制方法转变为持有安全库存，以避免因未达到采购目标而受到惩罚，并重组当地合作伙伴的债务以管理长期表现。

原创性/价值

本研究通过支持动态能力理论扩展了国际商务领域的新兴文献。